Impact Biomedical (IBO) Shares Outstanding (Entity) (2022 - 2026)
Impact Biomedical (IBO) reported Shares Outstanding (Entity) of 8.54 million for Q3 2026, down 29.9% from 12.19 million a year earlier and down 92.1% from the prior quarter.
Powered by 
Analysis
Impact Biomedical (IBO) Shares Outstanding (Entity) (2022 - 2026) Analysis & Trends
For FY2025, Impact Biomedical posted Shares Outstanding (Entity) of 31.55 million, up 174.3% from FY2024.
- Shares Outstanding (Entity) has a three-year compound annual growth rate of -23.5% (FY2022 to FY2025).
- By year, Shares Outstanding (Entity) came in at 11.5 million in FY2024 (-80.9%), 60.25 million in FY2023 (-14.5%) and 70.5 million in FY2022.
- The Q3 2026 figure ranks as the lowest quarterly Shares Outstanding (Entity) in data going back to Q2 2022.
- Year over year, Shares Outstanding (Entity) gained in six of the last eight quarters, with growth averaging 211.1%.
- The high point for year-over-year Shares Outstanding (Entity) in five years was Q1 2026 (growth of 792.2%); the low point was Q2 2023 (a decline of 98.2%).
- Per Business Quant data, the three quarters before Q3 2026 came in at 107.82 million (Q2 2026), 107.82 million (Q1 2026) and 31.55 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 940.75 Mn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 2.41 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 1.77 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 2.47 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 540.90 Mn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 1.24 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 5.70 Bn |
| 10 | Impact Biomedical | 43.92 Mn | 47.11 Mn | 15,000.00 | 8.54 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 8.54 Mn |
| Jun 30, 2026 | 107.82 Mn |
| Mar 31, 2026 | 107.82 Mn |
| Dec 31, 2025 | 31.55 Mn |
| Sep 30, 2025 | 12.19 Mn |
| Jun 30, 2025 | 12.19 Mn |
| Mar 31, 2025 | 12.09 Mn |
| Dec 31, 2024 | 11.50 Mn |
| Sep 30, 2024 | 11.50 Mn |
| Jun 30, 2024 | 10.00 Mn |
| Mar 31, 2024 | 10.00 Mn |
| Dec 31, 2023 | 60.25 Mn |
| Sep 30, 2023 | 70.50 Mn |
| Jun 30, 2023 | 70.50 Mn |
| Mar 31, 2023 | 70.50 Mn |
| Dec 31, 2022 | 70.50 Mn |
| Sep 30, 2022 | 70.50 Mn |
| Jun 30, 2022 | 3.88 Bn |
API Access
Impact Biomedical Shares Outstanding (Entity) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=IBO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-entity", "ticker": "IBO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=IBO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();